Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Potential efficacy of therapies targeting intrahepatic lesions after sorafenib treatment of patients with hepatocellular carcinoma

Fig. 3

Linear regression analysis of overall survival and survival after sorafenib treatment and time to treatment failure of sorafenib treatment. a Survival after sorafenib treatment correlated significantly with overall survival (r = 0.949). b Time to treatment failure of sorafenib treatment correlated with overall survival (r = 0.508) as well

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us